Life Sciences
Surface Oncology Is Set for Further Gains - How to Buy It
Here's our price objective.
Eyeing a Sell Setup in Alibaba but Possible Buys in 2 Other Names
The potential buy trades are in Invitae Corp. and Salesforce.com.
Pacific Biosciences Reaches Our Price Target: Now What?
Let's check out the charts and technical indicators.
Fingers Crossed for a Couple $2 Lottery Tickets in My Portfolio
T2 Biosystems and Tyme Technologies have both perked up of late after languishing for extended periods of time.
Medtronic Points Up, but Wait for More Strength to Buy
The technical indicators are mixed for the big medical device maker and suggest bulls are not strongly behind the latest advance in the shares.
How to Play Emergent BioSolutions Right Now
A correction in EBS could soon set up an attractive opportunity.
Novavax's Charts Get a Shot in the Arm
The $180 area is our intermediate-term price objective.
What the Charts Say About Veeva Systems Stock
Our latest analysis and trading strategy for the cloud healthcare software provider.
Avantor Stock: Are the Technicals and Fundamentals Aligned?
The shares have climbed nearly five-fold from their Covid nadir.
Edwards Lifesciences Is Poised for Upside Breakout
Consider adding or going long above this critical price level.